Europe PMC requires Javascript to function effectively.

Either your web browser doesn't support Javascript or it is currently turned off. In the latter case, please turn on Javascript support in your web browser and reload this page.

Search life-sciences literature (45,103,589 articles, preprints and more)

Search results

1-16 of 16 results

Sort by:

Relevance ^{Relevance: This is determined based on a ranking of criteria including term frequency, rarity of term, recency of article, whether there is a Title or Author field match, etc.}

Times cited

Date

Pasteurized akkermansia muciniphila improves irritable bowel syndrome-like symptoms and related behavioral disorders in mice.
Meynier M, Daugey V, Mallaret G, Gervason S, Meleine M, Barbier J, Aissouni Y, Lolignier S, Bonnet M, Ardid D, De Vos WM, Van Hul M, Suenaert P, Brochot A, Cani PD, Carvalho FA
Gut Microbes, 16(1):2298026, 03 Jan 2024
Cited by: 7 articles | PMID: 38170633 | PMCID: PMC10766393
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Ilixadencel, a Cell-based Immune Primer, plus Sunitinib Versus Sunitinib Alone in Metastatic Renal Cell Carcinoma: A Randomized Phase 2 Study.
Lindskog M, Laurell A, Kjellman A, Melichar B, Rey PM, Zieliński H, Villacampa F, Bigot P, Zoltan B, Parikh O, Alba DV, Jellvert Å, Flaskó T, Gallardo E, Caparrós MJR, Purkalne G, Suenaert P, Karlsson-Parra A, Ljungberg B
Eur Urol Open Sci, 40:38-45, 26 Apr 2022
Cited by: 7 articles | PMID: 35638086 | PMCID: PMC9142735
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Phase I trial evaluating safety and efficacy of intratumorally administered inflammatory allogeneic dendritic cells (ilixadencel) in advanced gastrointestinal stromal tumors.
Fröbom R, Berglund E, Berglund D, Nilsson IL, Åhlén J, von Sivers K, Linder-Stragliotto C, Suenaert P, Karlsson-Parra A, Bränström R
Cancer Immunol Immunother, 69(11):2393-2401, 13 Jun 2020
Cited by: 15 articles | PMID: 32535637 | PMCID: PMC7568699
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
ACCELERATE and European Medicines Agency Paediatric Strategy Forum for medicinal product development of checkpoint inhibitors for use in combination therapy in paediatric patients.
Pearson ADJ, Rossig C, Lesa G, Diede SJ, Weiner S, Anderson J, Gray J, Geoerger B, Minard-Colin V, Marshall LV, Smith M, Sondel P, Bajars M, Baldazzi C, Barry E, Blackman S, Blanc P, Capdeville R, Caron H, [...] Vassal G
Eur J Cancer, 127:52-66, 24 Jan 2020
Cited by: 26 articles | PMID: 31986450
Add to export list
Phase 1 Trial With the Cell-Based Immune Primer Ilixadencel, Alone, and Combined With Sorafenib, in Advanced Hepatocellular Carcinoma.
Rizell M, Sternby Eilard M, Andersson M, Andersson B, Karlsson-Parra A, Suenaert P
Front Oncol, 9:19, 21 Jan 2019
Cited by: 29 articles | PMID: 30719425 | PMCID: PMC6348253
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Ilixadencel - an Allogeneic Cell-Based Anticancer Immune Primer for Intratumoral Administration.
Karlsson-Parra A, Kovacka J, Heimann E, Jorvid M, Zeilemaker S, Longhurst S, Suenaert P
Pharm Res, 35(8):156, 14 Jun 2018
Cited by: 12 articles | PMID: 29904904 | PMCID: PMC6002422
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Future perspectives in melanoma research. Meeting report from the "Melanoma Bridge. Napoli, December 2nd-4th 2012".
Ascierto PA, Grimaldi AM, Acquavella N, Borgognoni L, Calabrò L, Cascinelli N, Cesano A, Del Vecchio M, Eggermont AM, Faries M, Ferrone S, Fox BA, Gajewski TF, Galon J, Gnjatic S, Gogas H, Kashani-Sabet M, Kaufman HL, Larkin J, [...] Thurin M
J Transl Med, 11:137, 03 Jun 2013
Cited by: 17 articles | PMID: 23731854 | PMCID: PMC3681569
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Kinetics of butyrate metabolism in the normal colon and in ulcerative colitis: the effects of substrate concentration and carnitine on the β-oxidation pathway.
De Preter V, Geboes KP, Bulteel V, Vandermeulen G, Suenaert P, Rutgeerts P, Verbeke K
Aliment Pharmacol Ther, 34(5):526-532, 26 Jun 2011
Cited by: 21 articles | PMID: 21707682
Add to export list
Effects of T cell-induced colonic inflammation on epithelial barrier function.
Suenaert P, Maerten P, Van Assche G, Van Driessche W, Geboes K, Bulteel V, Simaels J, Augustijns P, Ceuppens JL, Rutgeerts P, Perrier C
Inflamm Bowel Dis, 16(8):1322-1331, 01 Aug 2010
Cited by: 16 articles | PMID: 20155850
Add to export list
Pouchitis, similar to active ulcerative colitis, is associated with impaired butyrate oxidation by intestinal mucosa.
De Preter V, Bulteel V, Suenaert P, Geboes KP, De Hertogh G, Luypaerts A, Geboes K, Verbeke K, Rutgeerts P
Inflamm Bowel Dis, 15(3):335-340, 01 Mar 2009
Cited by: 25 articles | PMID: 18942762
Add to export list
Saccharomyces boulardii in Crohn's disease: effect on anti-Saccharomyces cerevisiae antibodies and intestinal permeability.
Joossens S, Suenaert P, Noman M, Vermeire S, Rutgeerts P
Inflamm Bowel Dis, 11(9):863-864, 01 Sep 2005
Cited by: 5 articles | PMID: 16116324
Add to export list
Hyperresponsiveness of the mucosal barrier in Crohn's disease is not tumor necrosis factor-dependent.
Suenaert P, Bulteel V, Vermeire S, Noman M, Van Assche G, Rutgeerts P
Inflamm Bowel Dis, 11(7):667-673, 01 Jul 2005
Cited by: 28 articles | PMID: 15973122
Add to export list
In vivo influence of nicotine on human basal and NSAID-induced gut barrier function.
Suenaert P, Bulteel V, Den Hond E, Geypens B, Monsuur F, Luypaerts A, Ghoos Y, Rutgeerts P
Scand J Gastroenterol, 38(4):399-408, 01 Apr 2003
Cited by: 20 articles | PMID: 12739712
Add to export list
The effects of smoking and indomethacin on small intestinal permeability.
Suenaert P, Bulteel V, Den Hond E, Hiele M, Peeters M, Monsuur F, Ghoos Y, Rutgeerts P
Aliment Pharmacol Ther, 14(6):819-822, 01 Jun 2000
Cited by: 38 articles | PMID: 10848667
Add to export list
Anti-tumor necrosis factor treatment restores the gut barrier in Crohn's disease.
Suenaert P, Bulteel V, Lemmens L, Noman M, Geypens B, Van Assche G, Geboes K, Ceuppens JL, Rutgeerts P
Am J Gastroenterol, 97(8):2000-2004, 01 Aug 2002
Cited by: 243 articles | PMID: 12190167
Add to export list
Severe knee pain as the single symptom of CMV infection in acute ulcerative colitis treated with cyclosporine.
D'Haens G, Suenaert P, Westhovens R, Rutgeerts P
Inflamm Bowel Dis, 4(1):27-28, 01 Feb 1998
Cited by: 4 articles | PMID: 9552225
Add to export list

1-16 of 16 results

Search life-sciences literature (45,103,589 articles, preprints and more)

Search results

Pasteurized akkermansia muciniphila improves irritable bowel syndrome-like symptoms and related behavioral disorders in mice.

Ilixadencel, a Cell-based Immune Primer, plus Sunitinib Versus Sunitinib Alone in Metastatic Renal Cell Carcinoma: A Randomized Phase 2 Study.

Phase I trial evaluating safety and efficacy of intratumorally administered inflammatory allogeneic dendritic cells (ilixadencel) in advanced gastrointestinal stromal tumors.

ACCELERATE and European Medicines Agency Paediatric Strategy Forum for medicinal product development of checkpoint inhibitors for use in combination therapy in paediatric patients.

Phase 1 Trial With the Cell-Based Immune Primer Ilixadencel, Alone, and Combined With Sorafenib, in Advanced Hepatocellular Carcinoma.

Ilixadencel - an Allogeneic Cell-Based Anticancer Immune Primer for Intratumoral Administration.

Future perspectives in melanoma research. Meeting report from the "Melanoma Bridge. Napoli, December 2nd-4th 2012".

Kinetics of butyrate metabolism in the normal colon and in ulcerative colitis: the effects of substrate concentration and carnitine on the β-oxidation pathway.

Effects of T cell-induced colonic inflammation on epithelial barrier function.

Pouchitis, similar to active ulcerative colitis, is associated with impaired butyrate oxidation by intestinal mucosa.

Saccharomyces boulardii in Crohn's disease: effect on anti-Saccharomyces cerevisiae antibodies and intestinal permeability.

Hyperresponsiveness of the mucosal barrier in Crohn's disease is not tumor necrosis factor-dependent.

In vivo influence of nicotine on human basal and NSAID-induced gut barrier function.

The effects of smoking and indomethacin on small intestinal permeability.

Anti-tumor necrosis factor treatment restores the gut barrier in Crohn's disease.

Severe knee pain as the single symptom of CMV infection in acute ulcerative colitis treated with cyclosporine.

Partnerships & funding